Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting. Tamilvanan Shunmugaperumal

Чтение книги онлайн.

СКАЧАТЬ C.M. (2012), Twenty years of drug nanocrystals: where are we, and where do we go?, Eur. J. Pharm. Biopharm., 80 (1), 1–3. doi:10.1016/j.ejpb.2011.09.012

      33 Napper, D.H. (1983), Polymeric Stabilisation of Colloidal Dispersions, Academic Press, London.

      34 Piemi, M.P., Korner, D., Benita, S. et al. (1999), Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs, J. Control. Release, 58, 177–187. doi:10.1016/s0168‐3659(98)00156‐4

      35 Shah, D.A., Murdande, S.B., and Dave, R.H. (2016), A review: pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions, J. Pharm. Sci., 105 (1), 10–24. doi:10.1002/jps.24694

      36  Shegokar, R. and Müller, R.H. (2010), Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives, Int. J. Pharm., 399 (1–2), 129–139. doi:10.1016/j.ijpharm.2010.07.044

      37 Skinner, L.M. and Sambles, J.R. (1972), Kelvin equation—a review, J. Aerosol. Sci., 3 (3), 199–210. doi:10.1016/0021‐8502(72)90158‐9

      38 Smith, A. and Davis, S.S. (1973), Proceedings: the role of molecular diffusion in the bulk stability of o‐w hydrocarbon emulsions, J. Pharm. Pharmacol., 25 (Suppl), 117.

      39 Tadros, T.F. (1982), Polymer adsorption and colloid stability, in: The Effect of Polymer on Dispersion Properties, Academic Press, London.

      40 Tadros, T.F., Izquierdo, P., Esquena, J. et al. (2004), Formation and stability of nanoemulsions, Adv. Colloid Interf. Sci., 108–109, 303–318. doi:10.1016/j.cis.2003.10.023

      41 Tamilvanan, S., Gursoy, R.N., and Benita, S. (2002), Emulsion‐based delivery systems for enhanced drug absorption, Pharm. Technol., 131, 156–161.

      42 Taniguchi, N. (1974), On the basic concept of nanotechnology, in: Proceedings of the International Conference on Production Engineering, Tokyo, Part‐II, Japan Society of Precision Engineering, Japan, pp. 18–23.

      43 Taylor, P. (1998), Ostwald ripening in emulsions, Adv. Colloid.Interf. Sci., 75 (2), 107–163. doi:10.1016/S0001‐8686(98)00035‐9

      44 Taylor, P. and Ottewill, R.H. (1994), Ostwald ripening in O/W miniemulsions formed by the dilution of O/W microemulsions, in: Progress in Colloid and Polymer Science, Springer, Berlin, Germany, pp. 199–203.

      45 Tuomela, A., Hirvonen, J., and Peltonen, L. (2016), Stabilizing agents for drug nanocrystals: effect on bioavailability, Pharmaceutics, 8 (2), 1–18. doi:10.3390/pharmaceutics8020016

      46 Vandamme, T.F. (2002), Microemulsions as ocular drug delivery systems: recent developments and future challenges, Prog. Retin. Eye Res., 21, 15–34. doi:10.1016/s1350‐9462(01)00017‐9

      47 Wagner, C. (1961), Theorie der alterung von niederschlägen durch umlösen (ostwaldreifung), Z. Elektrochem., 65 (7–8), 581–591. doi:10.1002/bbpc.19610650704

      48 Wassvik, C.M., Holmen, A.G., and Draheim, R. (2008), Molecular characteristics for solid‐state limited solubility, J. Med. Chem., 51 (10), 3035–3039. doi:10.1021/jm701587d

      49 Yotsuyanagi, T., Higuchi, W.I., and Ghanem, A.H. (1973), Theoretical treatment of diffusional transport into and through an oil‐water emulsion with an interfacial barrier at the oil‐water interface, J. Pharm. Sci., 62, 40–43. doi:10.1002/jps.2600620106

CHAPTER 2 FORMULATION DEVELOPMENT OF OIL‐IN‐WATER NANOSIZED EMULSIONS

SYED NAZRIN RUHINA RAHMAN* AND TAMILVANAN SHUNMUGAPERUMAL

      Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, India

      1  2.1. Introduction

      2  2.2. FDA‐approved oils, emulsifiers, and auxiliary or miscellaneous excipients 2.2.1. Issues related to oil selection to make the o/w nanosized emulsions for medical application 2.2.2. Issues related to emulsifiers selection to stabilize the o/w nanosized emulsions for medical application 2.2.3. Importance of charge‐stabilized nanosized emulsions 2.2.4. Importance of neutral‐charged (sterically‐stabilized) nanosized emulsions 2.2.5. Advantages of nanosized emulsions stabilized by mixed or multicomponent emulsifier molecules 2.2.6. ‘Stealth’ property of nanosized emulsions: in vitro demonstrations 2.2.7. Advantages of stabilizers in nanosized emulsions 2.2.8. Miscellaneous additives

      3  2.3. Current and near future direction 2.3.1. Colloidal particles‐stabilized emulsions

      4  2.4 Lipophilic API incorporation pattern into nanosized emulsions 2.4.1. Extemporaneous API Addition 2.4.2. De Novo Emulsion Preparation 2.4.3. Interfacial Incorporation Approach 2.4.4. Incorporation of Antibodies, DNA Protein, Oligonucleotide, or Heat Labile Molecules

      5  2.5 QbD approach to optimize emulsion 2.5.1. Case study for optimizing systematically a formula to make o/w nanosized Emulsions

      6  2.6. Conclusion References

      EXPANSION OF ABBREVIATIONS

apoapolipoproteinAIartificial intelligenceAPIactive pharmaceutical ingredientCCDcentral composite designCKCcetalkonium chlorideCMAscritical material attributesCMCchemistry, manufacturing, and controlCPPscritical process parametersCQAscritical quality attributesCTABcetyltrimethyl ammonium bromideDBPdi‐butyl‐phthalate2DEHPAbis(2‐ethylhexyl) hydrogen phosphateDMPCdimyristoylphosphatidylcholineDMPEdimyristoylphosphatidylethanolamineDOTAP1,2‐dioleoyl‐sn‐glycero‐3‐trimethylammoniumpropane2D PAGEtwo‐dimensional polyacrylamide gel electrophoresisDPPCdipalmitoylphosphatidylcholineELMemulsion liquid membranesFbDFormulation by DesignFMEAfailure mode effect analysisHLBhydrophilic–lipophilic balanceICimpression cytologyICHInternational Council for HarmonisationIVCMin vivo confocal microscopyMAmaterial attributeMCTmedium‐chain СКАЧАТЬ